You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T3011

Showing 1 - 25 of 203
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Malignant Melanoma Trial (T3011 + Cobimetinib)

Not yet recruiting
  • Melanoma
  • Malignant Melanoma
  • T3011 + Cobimetinib
  • (no location specified)
Mar 3, 2023

Advanced Solid Tumor, Sarcoma, HNSCC Trial in China (T3011)

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • T3011
  • Hefei, Anhui, China
  • +18 more
Oct 30, 2022

Advanced Solid Tumor, Lung Cancer, Liver Cancer Trial in China (T3011)

Recruiting
  • Advanced Solid Tumor
  • +4 more
  • T3011
  • Bengbu, Anhui, China
  • +6 more
Oct 24, 2022

Metastasis in Lung, Metastasis in Liver, Solid Tumor Trial in United States (T3011, T3011 + pembrolizumab)

Recruiting
  • Metastasis in Lung
  • +3 more
  • T3011
  • T3011 + pembrolizumab
  • Phoenix, Arizona
  • +3 more
Aug 26, 2021

Solid Tumor, Melanoma, NSCLC Trial in Australia, United States (T3011, T3011 + pembrolizumab)

Recruiting
  • Solid Tumor
  • +2 more
  • T3011
  • T3011 + pembrolizumab
  • Gilbert, Arizona
  • +7 more
Jun 22, 2021

Type 1 Diabetes Trial in Nijmegen, Rotterdam (gallium-68-exendin injection followed by PET/CT scan)

Recruiting
  • Type 1 Diabetes Mellitus
  • gallium-68-exendin injection followed by PET/CT scan
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Oct 8, 2020

Breast Reconstruction, Implant-Based Breast Reconstruction (IBBR) Trial in Worldwide (pre-pectoral IBBR, sub-pectoral IBBR)

Recruiting
  • Breast Reconstruction
  • Implant-Based Breast Reconstruction (IBBR)
  • pre-pectoral IBBR
  • sub-pectoral IBBR
  • Boston, Massachusetts
  • +24 more
Nov 1, 2021

Respiratory Syncytial Virus Trial in Worldwide (mRNA-1345)

Not yet recruiting
  • Respiratory Syncytial Virus
  • mRNA-1345
  • Glendale, Arizona
  • +47 more
Sep 27, 2023

Hepatitis D, Chronic Trial in Worldwide (JNJ-73763989, Placebo, Entecavir (ETV) monohydrate)

Active, not recruiting
  • Hepatitis D, Chronic
  • Redwood City, California
  • +68 more
Jan 17, 2023

Upper Limb Essential Tremor (UL ET) Trial in Canada, United States (BOTOX, Placebo for BOTOX)

Recruiting
  • Upper Limb Essential Tremor (UL ET)
  • BOTOX
  • Placebo for BOTOX
  • Hoover, Alabama
  • +39 more
Aug 22, 2022

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +38 more
Jan 25, 2023

Embolic Stroke of Undetermined Source Trial in Worldwide

Completed
  • Embolic Stroke of Undetermined Source
    • Stanford, California
    • +43 more
    Feb 3, 2021

    Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Venetoclax)

    Active, not recruiting
    • Multiple Myeloma
    • Aurora, Colorado
    • +39 more
    Mar 2, 2022

    Non Hodgkin Lymphoma Trial in Worldwide (Epcoritamab)

    Recruiting
    • Non Hodgkin Lymphoma
    • Palo Alto, California
    • +44 more
    Aug 12, 2022

    SLE Trial in Worldwide (ESK-001, Placebo)

    Recruiting
    • SLE
    • Anniston, Alabama
    • +138 more
    Jul 21, 2023

    Staphylococcus Aureus Bacteremia Trial in Worldwide (Cefazolin, Penicillin, Clindamycin)

    Recruiting
    • Staphylococcus Aureus Bacteremia
    • Garran, Australia Capital Territory, Australia
    • +73 more
    Feb 23, 2022

    Healthy Volunteer Trial in Lincoln (DISC-3405, Placebo)

    Not yet recruiting
    • Healthy Volunteer
    • Lincoln, Nebraska
      Celerion
    Sep 18, 2023

    Idiopathic Pulmonary Fibrosis Trial (BI 1015550, Placebo)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • BI 1015550
    • Placebo
    • New Haven, Connecticut
    • +134 more
    Jan 23, 2023

    Lung Diseases, Interstitial Trial (BI 1015550, Placebo)

    Recruiting
    • Lung Diseases, Interstitial
    • BI 1015550
    • Placebo
    • New Haven, Connecticut
    • +128 more
    Jan 23, 2023

    Eosinophilic Esophagitis Trial in Worldwide (CC-93538)

    Recruiting
    • Eosinophilic Esophagitis
    • Birmingham, Alabama
    • +300 more
    Aug 17, 2022

    Anaplastic Large-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin,

    Completed
    Has Results
    • Anaplastic Large-Cell Lymphoma
    • +2 more
    • brentuximab vedotin
    • +4 more
    • Gilbert, Arizona
    • +143 more
    Nov 1, 2021

    NSCLC Trial in Worldwide (Denosumab, Zoledronic acid, Placebo to Denosumab)

    Completed
    Has Results
    • Non-Small Cell Lung Cancer
    • Goodyear, Arizona
    • +73 more
    Oct 4, 2021

    Eosinophilic Esophagitis Trial in Worldwide (CC-93538, Placebo)

    Recruiting
    • Eosinophilic Esophagitis
    • Birmingham, Alabama
    • +417 more
    Jan 23, 2023

    Crohn's Disease Trial in Worldwide (Guselkumab, Golimumab, JNJ-78934804)

    Not yet recruiting
    • Crohn's Disease
    • Guselkumab
    • +3 more
    • Birmingham, Alabama
    • +167 more
    Jul 14, 2022

    Arthritis, Psoriatic Trial in Worldwide (Guselkumab, Placebo)

    Recruiting
    • Arthritis, Psoriatic
    • Chandler, Arizona
    • +263 more
    Jan 17, 2023